Zymergen integrates computational and manufacturing technologies to design, develop, and commercialize bio-based breakthrough products in a range of industries. Co. has developed a platform based on its collection of accessible biomolecules, its software and data science technology and its data driven microbe optimization processes. Utilizing its platform, Co. is building several businesses, including: advanced materials, which seeks to employ bio-advantaged molecules or microbes to develop and deliver products; and drug discovery, which utilizes its differentiated access to natural products as a source of chemical matter provided by its unified metagenomics database. The ZY average annual return since 2021 is shown above.
The Average Annual Return on the ZY average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether ZY average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ZY average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|